SIM
CBAY

Spark Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Spark Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-51,992
Closed -$76K – 308
2020
Q1 		$76K Sell
51,992
-218,025
-81% -$366K 0.04% 299
2019
Q4 		$529K Hold
270,017
– – 0.06% 340
2019
Q3 		$1.38M Buy
270,017
+27,817
+11% +$168K 0.18% 146
2019
Q2 		$1.73M Buy
242,200
+58,400
+32% +$661K 0.12% 213
2019
Q1 		$2.44M Buy
183,800
+59,500
+48% +$633K 0.11% 220
2018
Q4 		$978K Buy
+124,300
New +$1.18M 0.07% 320
2015
Q3 		– Sell
-11,300
Closed -$30K – 763
2015
Q2 		$30K Sell
11,300
-49,000
-81% -$201K ﹤0.01% 645
2015
Q1 		$417K Buy
+60,300
New +$579K 0.06% 409

Other funds holding CBAY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return